Title: Internal Medicine- Rheumatology: Osteoporosis; Scleroderma and Raynaud’s Disease; Rheumatoid Arthritis.
Course ID: IMrh
Faculty:
Linda Brecher D.O., F.A.C.O.I., F.A.C.R.
Associate Professor of Clinical Medicine, Division Chief of Rheumatology, Department of Internal Medicine, Rowan School of Osteopathic Medicine, Stratford, NJ
Lawrence Brent M.D.
Professor of Medicine, Division of Rheumatology, Department of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
Original Release Date: July 1, 2021 Expiration Date: July 1, 2024
TOPIC 1:Osteoporosis.
Upon completion of this session, the participant should be able to: GL, EBM, COMP
- Detect patients who are at risk for osteoporosis.
- Recognize the need for bone density testing as recommended by the International Society of Clinical Densitomethy and the National Osteoporosis Foundation guidelines.
- Differentiate the nonpharmacologic and pharmacologic treatments for osteoporosis as recommended by the National Osteoporosis Foundation guidelines.
TOPIC 2: Scleroderma and Raynaud’s Disease.
Upon completion of this session, the participant should be able to: GL, COMP
- Specify the clinical manifestations of scleroderma.
- Apply the ACR/EULAR classification criteria for systemic sclerosis.
- Utilize treatment available for symptomatic manifestations as per the current EULAR recommendations.
- Apply the diagnostic work-up and treatment of Raynaud’s Phenomenon.
TOPIC 3: Rheumatoid Arthritis.
Upon completion of this session, the participant should be able to: GL, COMP
- Demonstrate the role of genetics, environmental factors, immune cells, and proinflammatory cytokines in the pathogenesis of rheumatoid arthritis.
- Illustrate the clinical features, extra-articular manifestations, and complications of rheumatoid arthritis.
- Utilize and compare various methods of measuring disease activity in rheumatoid arthritis.
- Compare and contrast the mechanisms of action of current and emerging therapies for RA and prescribe treatment for patients with rheumatoid arthritis according to ACR guidelines.
- The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
- This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.